After the 4-week treatment period, compared with the DCM group, the ZGJTSXF group showed significantly reduced mRNA expression of PERK (Figure 5B), FoxO1 (Figure 5C), Bim (Figure 5D), PUMA (Figure 5E) and TNFSF10 (Figure 5F) in mice with DCM (P < 0.01). This evidence concerns the gene BCL2L11 and familial dilated cardiomyopathy.